AWM
CME icon

Abound Wealth Management’s CME Group CME Stock Holding History

Abound Wealth Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84K Sell
31
-13
-30% -$3.6K ﹤0.01% 542
2026
Q1 		$13.1K Buy
44
+4
+10% +$1.19K ﹤0.01% 484
2025
Q4 		$11K Buy
40
+1
+3% +$272 ﹤0.01% 491
2025
Q3 		$10.5K Buy
39
+1
+3% +$272 ﹤0.01% 479
2025
Q2 		$10.6K Sell
38
-1
-3% -$272 ﹤0.01% 434
2025
Q1 		$10.5K Sell
39
-24
-38% -$5.92K ﹤0.01% 394
2024
Q4 		$14.5K Sell
63
-1
-2% -$230 ﹤0.01% 332
2024
Q3 		$14.2K Buy
64
+4
+7% +$828 ﹤0.01% 356
2024
Q2 		$11.9K Sell
60
-8
-12% -$1.65K ﹤0.01% 338
2024
Q1 		$14.6K Buy
68
+7
+11% +$1.47K 0.01% 308
2023
Q4 		$12.9K Buy
61
+5
+9% +$1.07K 0.01% 332
2023
Q3 		$11.2K Hold
56
– – ﹤0.01% 308
2023
Q2 		$10.4K Buy
56
+9
+19% +$1.66K ﹤0.01% 325
2023
Q1 		$9K Buy
47
+10
+27% +$1.81K ﹤0.01% 300
2022
Q4 		$6.22K Buy
37
+9
+32% +$1.56K ﹤0.01% 320
2022
Q3 		$4.96K Buy
+28
New +$5.53K ﹤0.01% 370

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Abound Wealth Management's CME Position: Q2 2026 in Review

Abound Wealth Management reduced its CME Group (CME) stake by 30% in Q2 2026, selling an estimated $3.6K and leaving 31 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Abound Wealth Management first reported a position in CME in Q3 2022 and has held it in 16 quarters since. The position peaked at $14.6K in Q1 2024. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Abound Wealth Management held 31 shares of CME Group worth $6.84K as of Q2 2026.
  • Abound Wealth Management sold 13 CME Group shares in Q2 2026, an estimated $3.6K.
  • CME Group made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #542 holding.
  • Abound Wealth Management first reported a position in CME Group in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's CME Group position peaked at $14.6K in Q1 2024.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.